Effects of <i>ERBB2</i> amplicon size and genomic alterations of chromosomes 1, 3, and 10 on patient response to trastuzumab in metastatic breast cancer
Larry E. Morrison(Abbott Fund), John S. Coon(Rush University Medical Center), Matthew Kemper(Rush University Medical Center), Bita Tabesh(Rush University Medical Center), Marta Batus(Rush University Medical Center), Beth Blondin(Abbott (United States)), Lydia Usha(Rush University Medical Center), Ruta Rao(Rush University Medical Center), Susan Jewell(Netherlands Institute for Radio Astronomy)
Cited by 26
Related Papers
Fluorescence In Situ Hybridization (FISH) as an Ancillary Diagnostic Tool in the Diagnosis of Melanoma
|The American Journal of Surgical Pathology|2009|470
A Highly Specific and Discriminatory FISH Assay for Distinguishing Between Benign and Malignant Melanocytic Neoplasms
|The American Journal of Surgical Pathology|2012|227
The frequency and impact of ROS1 rearrangement on clinical outcomes in never smokers with lung adenocarcinoma
|Annals of Oncology|2013|125
Copy Number Gains in 11q13 and 8q34 Are Highly Linked to Prognosis in Cutaneous Malignant Melanoma
|Journal of Molecular Diagnostics|2011|81